» Articles » PMID: 39342257

Responsive Porous Microneedles with Riboflavin Ocular Microinjection Capability for Facilitating Corneal Crosslinking

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2024 Sep 28
PMID 39342257
Authors
Affiliations
Soon will be listed here.
Abstract

Riboflavin-5-phosphate (riboflavin) is the most commonly used photosensitizer in corneal crosslinking (CXL); while its efficient delivery into the stroma through the corneal epithelial barrier is challenging. In this paper, we presented novel responsive porous microneedles with ocular microinjection capability to deliver riboflavin controllably inside the cornea to facilitate CXL. The microneedle patch was composed of Poly (N-isopropyl acrylamide) (PNIPAM), graphene oxide (GO), and riboflavin-loaded gelatin. After penetrating the cornea by the stiff and porous gelatin needle tip, the photothermal-responsive characteristic of the PNIPAM/GO hydrogel middle layer could realize the contraction of the gel under the stimulation of near-infrared light, which subsequently could control the release of riboflavin from the backing layer into the cornea stromal site both in vitro and in vivo. Based on the microneedles system, we have demonstrated that this microinjection technique exhibited superior riboflavin delivery capacity and treatment efficacy to the conventional epithelial-on protocol in a rabbit keratoconus model, with benefits including minimal invasiveness and precise administering. Thus, we believe the responsive porous microneedles with riboflavin ocular microinjection capability are promising for clinical corneal crosslinking without epithelial debridement.

Citing Articles

Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment.

Cao J, Wu B, Yuan P, Liu Y, Hu C Pharmaceutics. 2025; 16(12.

PMID: 39771550 PMC: 11676655. DOI: 10.3390/pharmaceutics16121571.

References
1.
Santodomingo-Rubido J, Carracedo G, Suzaki A, Villa-Collar C, Vincent S, Wolffsohn J . Keratoconus: An updated review. Cont Lens Anterior Eye. 2022; 45(3):101559. DOI: 10.1016/j.clae.2021.101559. View

2.
Borchert G, Tan J . Munson's Sign in Keratoconus. N Engl J Med. 2023; 389(10):939. DOI: 10.1056/NEJMicm2300297. View

3.
Zhang X, Wang Y, Chi J, Zhao Y . Smart Microneedles for Therapy and Diagnosis. Research (Wash D C). 2021; 2020:7462915. PMC: 7877383. DOI: 10.34133/2020/7462915. View

4.
Pacheco C, Baiao A, Ding T, Cui W, Sarmento B . Recent advances in long-acting drug delivery systems for anticancer drug. Adv Drug Deliv Rev. 2023; 194:114724. DOI: 10.1016/j.addr.2023.114724. View

5.
Aytekin E, Ozturk N, Vural I, Polat H, Cakmak H, Calis S . Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment. J Control Release. 2020; 324:238-249. DOI: 10.1016/j.jconrel.2020.05.017. View